Watch ASMB. Know when insiders buy.
One email the day a filing lands. Free.
ASMB
ASSEMBLY BIOSCIENCES, INC.
36.60
+0.47 +1.30%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
52
WATCH · shorts 52
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $745.2MP/E 35.9DIV YIELD —FCF YIELD -5.18%REV TTM —NET INCOME −$42KNET CASH $31.9M52W 20.55 – 38.50SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$6.3M | −$3.9M | — | -0.20 | −$15.5M | $0 | −$15.5M | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$11.4M | −$9.1M | — | -0.54 | −$22.1M | $19K | −$22.1M | May 7 |
| Q4 2025 · Dec 31derived | — | — | — | $19.8M | $22.1M | — | 2.48 | $14.2M | $24K | $14.2M | Mar 19 |
| Q3 2025 · Sep 30 | — | — | — | −$10.9M | −$9.2M | — | -0.72 | −$15.1M | $42K | −$15.2M | Nov 10 |
| Q2 2025 · Jun 30 | — | — | — | −$11.1M | −$10.2M | — | -1.33 | −$16.8M | $0 | −$16.8M | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$9.9M | −$8.8M | — | -1.17 | −$23.4M | $0 | −$23.4M | May 7 |
| Q4 2024 · Dec 31derived | — | — | — | −$11.5M | −$10.3M | — | -1.57 | −$407K | $0 | −$407K | Mar 19 |
| Q3 2024 · Sep 30 | — | — | — | −$11M | −$9.6M | — | -1.51 | −$15.2M | $0 | −$15.2M | Nov 10 |
| Q2 2024 · Jun 30 | — | — | — | −$12.2M | −$11.2M | — | -1.98 | −$17.1M | $14K | −$17.1M | Aug 6 |
| Q1 2024 · Mar 31 | — | — | — | −$10.7M | −$9.1M | — | -1.66 | −$18.4M | $14K | −$18.4M | May 8 |
| Q4 2023 · Dec 31derived | — | — | — | −$12.6M | −$11M | — | -1.77 | $73.6M | $71K | $73.6M | Mar 20 |
| Q3 2023 · Sep 30 | — | — | — | −$15M | −$14.4M | — | -3.29 | −$13.8M | $136K | −$14M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $72.3M | — | −$12.1M | −$6.1M | -8.5% | -0.55 | −$41.1M | $66K | −$41.2M | — | — |
| FY2024 · to Dec 31 | $28.5M | — | −$45.4M | −$40.2M | -140.9% | -6.69 | −$51.1M | $28K | −$51.1M | — | — |
| FY2023 · to Dec 31 | — | — | −$64.6M | −$61.2M | — | -13.38 | $22.7M | $255K | $22.5M | — | — |
| FY2022 · to Dec 31 | — | — | −$94.1M | −$93.1M | — | -23.08 | −$84.5M | $102K | −$84.6M | — | — |
| FY2021 · to Dec 31 | — | — | −$132.7M | −$129.9M | — | -3.00 | −$93.4M | $3.1M | −$96.5M | — | — |
| FY2020 · to Dec 31 | — | — | −$64.8M | −$62.2M | — | -1.75 | −$63M | $470K | −$63.4M | — | — |
Every number comes from ASSEMBLY BIOSCIENCES, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.